Lewis, G. D., Li, G., Guo, J., Yu, S., Fields, C. T., Lee, G., . . . Cho, E. (2024, January). The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: Preclinical characterization and phase 1 trial results. Nature Communications.
Chicago Style (17th ed.) CitationLewis, Gail D., et al. "The HER2-directed Antibody-drug Conjugate DHES0815A in Advanced And/or Metastatic Breast Cancer: Preclinical Characterization and Phase 1 Trial Results." Nature Communications Jan. 2024.
MLA (9th ed.) CitationLewis, Gail D., et al. "The HER2-directed Antibody-drug Conjugate DHES0815A in Advanced And/or Metastatic Breast Cancer: Preclinical Characterization and Phase 1 Trial Results." Nature Communications, Jan. 2024.
Warning: These citations may not always be 100% accurate.
